SITC has provided comments on a recently released FDA Draft Guidance: "Optimizing the Dosage of Human Prescription Drugs and Biological Products Used in the Treatment of Oncologic Diseases; Draft Guidance for Industry". Please find the letter in its entirety HERE.
#Policy